BACKGROUND: Hydrogen sulphide (H(2)S) has recently emerged as a novel and important gasotransmitter in the cardiovascular system, where it is generated mainly by cystathionine gamma-lyase (CSE). Abnormal metabolism and functions of the CSE/H(2)S pathway have been linked to various cardiovascular diseases including atherosclerosis and hypertension. An important role for H(2)S in regulating the balance between cellular growth and death has been demonstrated whereby inhibition of the endogenous CSE/H(2)S pathway results in greater apoptosis of vascular smooth muscle cells (SMCs). H(2)S is increasingly recognized as a critical regulator of vascular integrity, but its role in SMCs during hypoxia has not been explored in a model of CSE deficiency. METHODS: Cell viability, apoptosis, redox status and mitochondrial activity in hypoxia-exposed (12 h at 1% O(2)) SMCs derived from the mesenteric artery of CSE-knockout (CSE-KO) mice were analyzed. These were compared with those from CSE-wild-type (CSE-WT) mice. RESULTS: CSE-KO cells exhibited redox imbalance and aberrant mitochondrial activity versus CSE-WT cells, indicating an essential regulatory role for the endogenous CSE/H(2)S pathway on SMC function. CSE-KO cells were also more susceptible to hypoxia-induced cell death, indicating a critical contribution of endogenous CSE/H(2)S pathway to the protective hypoxia stress response. CONCLUSION: These findings support the concept that H(2)S is a crucial regulator of vascular homeostasis, the deficiency of which is associated with various pathologies, and provide further evidence that H(2)S is a potent vasculoprotectant.
BACKGROUND:Hydrogen sulphide (H(2)S) has recently emerged as a novel and important gasotransmitter in the cardiovascular system, where it is generated mainly by cystathionine gamma-lyase (CSE). Abnormal metabolism and functions of the CSE/H(2)S pathway have been linked to various cardiovascular diseases including atherosclerosis and hypertension. An important role for H(2)S in regulating the balance between cellular growth and death has been demonstrated whereby inhibition of the endogenous CSE/H(2)S pathway results in greater apoptosis of vascular smooth muscle cells (SMCs). H(2)S is increasingly recognized as a critical regulator of vascular integrity, but its role in SMCs during hypoxia has not been explored in a model of CSE deficiency. METHODS: Cell viability, apoptosis, redox status and mitochondrial activity in hypoxia-exposed (12 h at 1% O(2)) SMCs derived from the mesenteric artery of CSE-knockout (CSE-KO) mice were analyzed. These were compared with those from CSE-wild-type (CSE-WT) mice. RESULTS:CSE-KO cells exhibited redox imbalance and aberrant mitochondrial activity versus CSE-WT cells, indicating an essential regulatory role for the endogenous CSE/H(2)S pathway on SMC function. CSE-KO cells were also more susceptible to hypoxia-induced cell death, indicating a critical contribution of endogenous CSE/H(2)S pathway to the protective hypoxia stress response. CONCLUSION: These findings support the concept that H(2)S is a crucial regulator of vascular homeostasis, the deficiency of which is associated with various pathologies, and provide further evidence that H(2)S is a potent vasculoprotectant.
Authors: Kenneth R Olson; Nathan L Whitfield; Shawn E Bearden; Judy St Leger; Erika Nilson; Yan Gao; Jane A Madden Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-11-04 Impact factor: 3.619
Authors: Viktória Jeney; Edina Komódi; Emõke Nagy; Abolfazl Zarjou; Gregory M Vercellotti; John W Eaton; György Balla; József Balla Journal: Free Radic Biol Med Date: 2008-12-06 Impact factor: 7.376
Authors: Rafael O Fernandes; Jéssica H P Bonetto; Boran Baregzay; Alexandre L de Castro; Stephanie Puukila; Heidi Forsyth; Paulo C Schenkel; Susana F Llesuy; Ilma Simoni Brum; Alex Sander R Araujo; Neelam Khaper; Adriane Belló-Klein Journal: Mol Cell Biochem Date: 2014-12-07 Impact factor: 3.396
Authors: Tamara Merz; Tatjana Stenzel; Benedikt Nußbaum; Martin Wepler; Csaba Szabo; Rui Wang; Peter Radermacher; Oscar McCook Journal: Intensive Care Med Exp Date: 2017-03-21